Kind Pharmaceuticals Llc

This study tests a new drug called AND017 for anemia caused by a bone marrow disorder called lower-risk myelodysplastic syndromes (MDS). About 63 adults with MDS who need few or no blood transfusions will receive different doses of AND017 to see if it can raise hemoglobin levels …

This study tests an oral drug called AND017 in people with β-thalassemia, a blood disorder that often requires regular blood transfusions. The trial includes 64 adults who either need transfusions or do not. Participants receive AND017 or a placebo along with standard care. The g…

This study tests a new medicine called AND017 for anemia caused by chronic kidney disease. About 240 adults with moderate to severe kidney disease who are not on dialysis will receive either AND017 or a standard treatment. The goal is to see if AND017 can safely keep hemoglobin l…

This study tests a new medicine called AND017 for people with anemia caused by end-stage kidney disease who are on dialysis. The goal is to see if AND017 works better than current treatments at keeping red blood cell levels stable. About 300 adults will take part, and the study i…